Anafranil Articles
Novartis sells off old CNS drugs in USA
25 June 2001
Novartis ties up with Cephalon in UK marketing pact
7 December 2000
Taro And Mylan Gain FDA Approvals
13 January 1997
CoCensys Sales Force Ahead Of Schedule
25 July 1994
CIBA AND COCENSYS IN PRODUCT LINK-UP
23 May 1994
OCD PATIENTS RESPOND TO FLUVOXAMINE
1 November 1993
ANAFRANIL DATA FALSIFIED
16 August 1993
FURTHER INDICATION FOR LILLY'S PROZAC?
26 July 1993
WORLD CNS MARKET IS LARGE AND FRAGMENTED
22 February 1993
Showing 1-10 of 10 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
